Showing results (821-830 of 1,256) with videos related to
Sort By:
Pageof 126
Neuroimmunomodulation|April 19, 2013
TRAF2 is upregulated in relapsing-remitting multiple sclerosisReinhard Reuß, Andreas Mirau, Marta Mistarz, et al.Neuroimmunomodulation|February 15, 2013
Acute painful stress and inflammatory mediator productionCharles A Griffis, Elizabeth Crabb Breen, Peggy Compton, et al.Neuroimmunomodulation|January 9, 2013
Helicobacter pylori infection in Neuromyelitis Optica and Multiple SclerosisYouming Long, Cong Gao, Wei Qiu, et al.Neuroimmunomodulation|December 14, 2012
Neuroimmune interactions in Sjögren's syndrome: relationship of exocrine gland dysfunction with autoantibodies to muscarinic acetylcholine receptor-3 and mental health status parametersMagdolna Deák, Attila Szvetnik, Attila Balog, et al.Neuroimmunomodulation|September 18, 2014
Glucocorticoids in juvenile idiopathic arthritisBenedetta Schiappapietra, Giulia Varnier, Silvia Rosina, et al.Neuroimmunomodulation|September 18, 2014
One hormone, two actions: anti- and pro-inflammatory effects of glucocorticoidsDiana Cruz-Topete, John A CidlowskiNeuroimmunomodulation|September 18, 2014
11β-hydroxysteroid dehydrogenase enzymes modulate effects of glucocorticoids in rheumatoid arthritis synovial cellsMartin Schmidt, Rainer H StraubNeuroimmunomodulation|September 18, 2014
Initial high-dose prednisolone combination therapy using COBRA and COBRA-light in early rheumatoid arthritisLinda A Rasch, Lilian H D van Tuyl, Willem F Lems, et al.Neuroimmunomodulation|September 18, 2014
Safety of glucocorticoids in rheumatoid arthritis: evidence from recent clinical trialsTânia Santiago, José António P da SilvaNeuroimmunomodulation|September 18, 2014
Glucocorticoids in early rheumatoid arthritis: are the benefits of joint-sparing effects offset by the adverse effect of osteoporosis? the effects on bone in the utrecht study and the CAMERA-II studyJohannes W G Jacobs, Johannes W J Bijlsma, Jacob M van LaarPageof 126